Investor Presentaiton

Our Strive25 strategy will drive continued long-term value creation through revenue and earnings growth مرا 100 7-9% organic growth p.a. more than 30% EBIT margin¹ 1 Constant currencies, based on FX rate as of September 29, 2020 23 Interventional Urology Innovation Ostomy Care J Continence Care Strive 25 SUSTAINABLE GROWTH LEADERSHIP Wound and Skin Care (o Voice and Respiratory Care * Leadership, culture and organization Efficiency Sustainability Coloplast

View entire presentation